This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,317.60 delivery order contract is for the supply of a specific pharmaceutical product, Veozah 45 mg tablets, with a period of performance through November 15, 2024.
The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract does not have a set-aside designation, indicating open competition.
In addition to the DLA contract, AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/13/25, 9:18 AM